Raymond James Financial Services Advisors, Inc. Trillium Therapeutics Inc. Transaction History

Raymond James Financial Services Advisors, Inc.

  • $73.5 Billion
  • Q3 2024

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2021

Aug 11, 2021
SELL
N/A
-13,581 Closed
0 $0
Q1 2021

May 14, 2021
BUY
N/A
2,781 Added 25.75%
13,581 $146,000
Q4 2020

Feb 12, 2021
SELL
N/A
-2,500 Reduced 18.8%
10,800 $159,000
Q3 2020

Nov 04, 2020
BUY
N/A
1,500 Added 12.71%
13,300 $189,000
Q2 2020

Jul 17, 2020
BUY
N/A
11,800 New
11,800 $95,000

About Trillium Therapeutics Inc.

TRIL Quotes by TradingView
  • Ticker TRIL
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 104,995,000
  • Market Cap $1.94B
More about TRIL
Track This Portfolio

Track Raymond James Financial Services Advisors, Inc. Portfolio

Follow Raymond James Financial Services Advisors, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Raymond James Financial Services Advisors, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Raymond James Financial Services Advisors, Inc. with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email